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Abstract The aim of this study was to evaluate the influence
of the intake of L -arginine alone and of L-arginine with
vitamin C on mineral concentration in rats fed with a high-
fat diet, and to assess the lipid glucose, insulin, and total
antioxidant status (TAS) and tumor necrosis factor (TNF)
alpha serum levels that result. Wistar rats were assigned to
groups fed with either a standard control diet (C), a diet high in
fat (FD), a diet high in fat with L-arginine, or a diet high in fat
with L-arginine and vitamin C. After 6 weeks, the length and
weight of the rats were measured, and the animals were
euthanized. The liver, spleen, kidneys, pancreas, heart, and
gonads were collected, as were blood samples. The total
serum cholesterol, triglyceride, fasting glucose, insulin, TAS,
and TNF alpha levels were measured. The tissue calcium,
magnesium, iron, zinc, and copper concentrations were deter-
mined. It was found that L-arginine supplementation dimin-
ished the effect of the modified diet on the concentration of
iron in the liver and spleen and of copper in heart. At the same
time, it was observed that L-arginine supplementation reduced
the effect of the high-fat diet on insulin, TNF alpha, and TAS.
The combination of L-arginine and vitamin C produced a
similar effect on the mineral levels in the tissues as did L-
arginine used alone. Moreover, positive correlations between
serum insulin and iron in the liver, between TNF alpha and
iron in the liver, and between TNF alpha and copper in the
heart were observed. The level of TAS in serum was inversely
correlated with the copper level in the heart and the iron level
in the liver. We concluded that the beneficial influence of L-
arginine on insulin, TAS, and TNF alpha serum level is
associated with changes in the iron and copper status in rats
fed with a high-fat diet. No synergistic effect of L-arginine and
vitamin C in the biochemical parameters or in the mineral
status in rats fed with the modified diet was observed.
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Introduction
Unbalanced diets have contributed to the increased prevalence
of obesity and other metabolic disorders in the modern world
[1]. Experimental and clinical research have shown that high-
fat diets lead to increased serum glucose, insulin, and triglyc-
eride levels and promote insulin resistance, oxidative stress,
and inflammation [2, 3]. Moreover, it has been observed that
both the western diet (high in fat, sodium, and sugar) and
metabolic disorders are associated with impairments in min-
eral status [4]. An increasing amount of evidence suggests that
mineral disturbances are involved in complex pathogenesis of
obesity-related complications. An association has been dem-
onstrated between mineral status on the one hand and antiox-
idant markers, inflammation markers, glucose metabolism,
and lipid metabolism on the other. Recent studies have indi-
cated that it is worth considering mineral control and supple-
mentation in some populations, including patients with obesi-
ty and related diseases [5–7].
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Due to the high incidence of metabolic disorders, com-
pounds that might prevent or treat them are sought for. It is
known that a significant deficiency in nitric oxide (NO) is one
of the disorders contributing to metabolic syndrome. The
substrate for NO synthesis is L-arginine. Increasingly, the
evidence points to the potential benefits of the use of L-
arginine for decreasing oxidative stress, decreasing blood
pressure, reducing the severity of atherosclerosis, and improv-
ing insulin sensitivity [8–11]. Its precise mechanism, however,
has not yet been fully determined. The potential use of L-
arginine in patients with obesity and other metabolic disorders
seems to be promising, especially when combined with other
substances with similar properties—for example, antioxidants
[12–14]. There is a lack of experimental research assessing L-
arginine supplementation under the condition of metabolic
disorders caused by a diet high in fat in rats, and also the
influence of L-arginine on mineral status in rats.
Considering the beneficial properties of L-arginine, we
have carried out a study to evaluate the influence of L-arginine
alone and with vitamin C on mineral status in rats, and to
assess the resulting changes in lipid, glucose, insulin, antiox-
idant, and inflammation status in rats fed with a diet that
promotes metabolic disorders.
Materials and Methods
All animal procedures were performed according to approved
protocols and in accordance with the recommendations for the
proper care and use of laboratory animals. The protocol of the
study was approved by the local bioethical commission in
Poznań (approval no. 20/2011).
Animals
The experiment was performed using male Wistar rats
(8 weeks old, weighing 191±10 g). The rats were purchased
from the Department of Toxicology at the Medical University
of Poznan, Poland. All rats were housed individually in poly-
carbonate cages in a room controlled for temperature and
humidity on a 12-h light, 12-h dark cycle, designed for the
purpose of the study. The indoor animal house temperature
was 21±2 °C and the relative humidity was 60±5 %. The
animals were housed under standard conditions.
Experimental Design
The experiment was performed using 24 male Wistar rats.
After a 5-day period of adaptation to laboratory conditions, the
rats were randomly divided into four equally sized groups:
Group 1, the control (C, n =6): untreated rats, allowed
free access to standard diet
Group 2, high-fat diet (FD, n =6): received a high-fat diet
Group 3, arginine group (FD + ARG; n =6): received a
high-fat diet containing 20 g/kg diet of L-arginine
Group 4, arginine and vitamin C group (FD+ARG+
VITC; n =6): received a high-fat diet containing 20 g/kg
diet of L-arginine and 100 mg/kg diet of vitamin C
The animals were fed with either a standard semisynthetic
diet based on the AIN-93 M diet [15] or a high-fat diet
modified with amounts of fat and sodium chloride. The full
composition of the diets is presented in Tables 1 and 2. L-
arginine (Curtis Healthcare, Warsaw, Poland) was adminis-
tered in the diet at a dose of 20 g/kg diet for 6 weeks. Vitamin
C (Biofarm, Poznan, Poland) was administered in the diet at a
dose of 100 mg/kg diet for 6 weeks. The appropriate value of
wheat starch was reduced in the diet—20 g for L-arginine and
100 mg for vitamin C.
All rats were provided ad libitum diet and distilled water
for 42 days. Dietary intake was recorded daily, while body
weight gain was monitored weekly before food distribution
(Table 3).
Over the whole course of the experiment, the animals were
under veterinary supervision.
Tissue and Serum Collection
At the end of the experimental period and following 16 h of
fasting, the animals were weighed and anesthetized with a
sodium thiopental injection (40 mg/kg body weight), and
killed by cardiac puncture. The blood samples were collected
in serum-separated tubes for biochemical studies. The blood
was left to clot at room temperature for 30 min, and then
centrifuged for 15 min at 2,500 rpm at 4 °C. The supernatant
fluid was then separated. Serum samples were stored at
−70 °C until analyzed. The liver, spleen, heart, kidneys, pan-
creas, and gonads were dissected, weighed, and kept frozen at
−70 °C until mineral content analysis was performed. In all
animals, the weight gain and the absolute and relative weight
of the tissues was determined. The relative weight of tissues
was defined as their percentage of body weight.
Biochemical Measurements
Total cholesterol, triglyceride, and fasting glucose levels in
serum were measured using commercial kits (Randox Labo-
ratories Ltd., UK) in the diagnostic laboratory at Poznan,
Poland. The concentration of cholesterol and triglycerides in
serum was assayed by the enzymatic method (Siemens
Healthcare Diagnostics, Erlangen, Germany). Serum glucose
concentration was assayed by an enzymatic method involving
hexokinase and glucose-6-phosphate dehydrogenase (Sie-
mens Healthcare Diagnostics, Erlangen, Germany).
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The plasma concentration of insulin was determined by an
enzyme-linked immunosorbent assay, strictly according to the
manufacturer’s instructions (Demeditec Diagnostic GmbH,
Kiel–Wellsee, Germany).
Insulin resistance was estimated using homeostasis model
assessment according to the following formula: insulin resis-
tance index = fasting insulin (in micrograms per liter)×fasting
glucose (in milligrams per deciliter)/405.
The plasma level of tumor necrosis factor (TNF) alpha was
determined by enzyme-linked immunosorbent assay, strictly
according to the manufacturer’s instructions (R&D Systems,
Minneapolis, USA).
The total antioxidant status (TAS) was measured using a
TAS Randox kit (Randox Laboratories Ltd., UK) and spec-
trophotometry (SPECORDM40, Carl Zeiss, Jena, Germany).
Determination of Minerals
The calcium, magnesium, iron, zinc, and copper contents of
the tissues were determined after digesting the tissues in 65 %
(w/w) spectra pure HNO3 (Merck) in the Microwave Diges-
tion System (MARS 5, CEM Corp., USA). The concentra-
tions of the minerals in the mineral solutions were then mea-
sured using flame atomic absorption spectrometry (AAS-3,
Carl Zeiss, Jena, Germany), at the following wavelengths:
422.7 nm for calcium, 285.2 nm for magnesium, 248.3 nm
for iron, 213.9 nm for zinc, and 324.8 nm for copper. The
accuracy of the method was verified with certified reference
materials (pig kidney BCR no. 186, Brussels) and was 92 %
for calcium, 98 % for magnesium, 92 % for iron, 95 % for
zinc, and 102 % for copper. The concentrations of minerals in
the tissues were expressed as wet weights.
Statistical Analysis
A detailed statistical analysis was performed using Statistica
for Windows 10.0. The results were expressed as arithmetic
means and standard errors. Continuous variables were
assessed for normal distribution with the use of the Shapiro–
Wilk test. Differences between means were analyzed by one-
way analysis of variance, followed by a post hoc Tukey’s test.
A value of P <0.05 was regarded as representing a significant
difference.
Results
The average intakes of diet and obesity indices were found to
be comparable in all groups (Table 3). The relative masses of
the tissues (as percentages of body mass) were also compara-
ble among the groups (Table 3).
The results presented in Table 4 demonstrate that 6 weeks
of high-fat diet resulted in a significant increase in serum
insulin and TNF alpha concentration and a decrease in TAS
Table 1 Ingredient and nutrient composition of the diets (grams per
kilogram diet)
Ingredient Standard diet High fat diet
Casein 140 140
Wheat starch 625 430
Sucrose 100 100
Potato starch 50 50
Vitamin mixturea 10 10
Mineral mixtureb 35 35
Sunflower oil 40 40
Lard - 160
Sodium chloride - 35
Total energy (kcal/100 g diet) 420 515
Total protein (% of energy) 18 18
Total fat (% of energy) 9 39
a Composition of vitamin mixture (g/kg mix): nicotinic acid (3), Ca
pantothenate (1.6), pyridoxine (0.7), thiamin (0.6), riboflavin (0.6), folic
acid (0.2), biotin (0.02), vitamin B12 (0.003), vitamin E (500 IU/g),
vitamin A (500,000 IU/g), vitamin D3 (400,000 IU/g), vitamin K1
(0.08), choline bitartrate (200), powdered sucrose (777.15)
b Composition of mineral mixture (g/kg mix): calcium carbonate (357),
potassium phosphate monobasic (250), potassium citrate (28), sodium
chloride (74), potassium sulfate (46.6), magnesium oxide (24), ferric
citrate (6.06), zinc carbonate (1.65), sodium meta-silicate⋅9H20 (1.45),
manganous carbonate (0.64), cupric carbonate (0.30), chromium
chloride⋅6H20 (0.147), boric acid (0.0816), sodium fluoride (0.0635),
nickel chloride⋅6H20 (0.0578), lithium sulfate⋅H20 (0.0263), sodium sel-
enate anhydrous (0.0103), potassium iodate (0.010), ammonium
paramolybdate⋅4H20 (0.0795), ammonium vanadate (0.066), powdered
sucrose (209.758)
Table 2 Minerals concentration
in the diets
C control group, FD high-fat diet
group, FD + ARG high-fat diet
with L-arginine group, FD +
ARG + VITC high-fat diet with L-
arginine and vitamin C group
Parameter Group
C FD FD + ARG FD + ARG + VITC
Ca (g/kg) 11.78±0.07 11.60±0.28 11.72±0.40 11.82±0.51
Mg (mg/kg) 538.27±6.48 543.03±15.03 535.54±11.80 545.27±14.12
Fe (mg/kg) 43.20±1.76 43.73±3.84 44.18±1.70 45.92±1.52
Zn (mg/kg) 29.83±4.90 31.65±3.07 28.25±1.70 30.89±2.49
Cu (mg/kg) 5.72±0.25 5.47±0.34 5.52±3.34 5.76±0.29
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serum levels, while L-arginine supplementation (both supple-
mented alone and in combination with vitamin C) diminished
the effects of the high-fat diet on insulin, TNF alpha, and TAS.
It was observed that L-arginine with vitamin C had a slightly
better influence on the biochemical parameters than did L-
arginine alone. Serum glucose, cholesterol, and triglyceride
levels were comparable among the groups.
In Table 5, the results of the mineral concentration analyses
of the tissues are given. It was found that the high-fat diet led
to a significant increase in the iron concentration in the liver
and in the copper level in the heart. At the same time, the level
of iron in the spleen markedly decreased under the influence
of the high-fat diet. L-arginine supplementation diminished
the effect of the modified diet on the concentration of iron in
the liver and spleen and copper in the heart (see Table 5).
The combination of L-arginine with vitamin C had a similar
effect on the mineral level in the tissues as did L-arginine used
alone.
Several correlations were found between serum insulin,
TAS, and TNF alpha and iron and copper levels in all rats
(Table 6). Serum insulin positively correlated with the iron
level in the liver. The value of the TAS in serum was inversely
correlated with the copper level in the heart and the iron level
in the liver. Moreover, a positive correlation of TNF alpha
level with the iron concentration in the liver, and also with the
copper concentration in the heart, was observed.
Discussion
In this study, we have demonstrated that 6 weeks of treatment
with L-arginine diminishes the effect of the high-fat diet on
insulin serum level, inflammation, and antioxidant status, and
was associated with changes in the iron and copper status of
rats. This is a new finding of the study. The influence of L-
arginine supplementation in improving insulin status has also
been observed in other experimental and clinical studies [9,
16]. In particular, it has been shown that L-arginine stimulates
insulin secretion [17, 18]. In our previous study, we found that
supplementation with L-arginine increases antioxidant status
in obese patients [13]. The antioxidant effects of L-arginine
could be due to the decreasing intensity of radical reactions or
Table 3 Final body mass, obesi-
ty index, and relative weight of
tissues
C control group, FD high-fat diet
group, FD + ARG high-fat diet
with L-arginine group, FD +
ARG + VITC high-fat diet with L-
arginine, and vitamin C group;
obesity index was calculated by
dividing the cubic root of the
body weight (grams) by the
nasoanal length (millimeters)×
104 ; the means are not signifi-
cantly different (P>0.05)
Parameter Group
C FD FD + ARG FD + ARG + VITC
Diet intake (g/day) 21.5±1.8 20.5±1.2 20.8±1.5 20.8±1.7
Final body mass (g) 343.0±34.7 345.8±28.8 333.0±36.3 323.2±41.2
Obesity index 303.00±34.68 292.65±28.86 281.00±36.28 303.17±41.21
Liver (%of body mass) 3.06±0.19 2.85±0.17 2.80±0.16 2.88±0.17
Kidney (% of body mass) 0.71±0.15 0.74±0.03 0.72±0.05 0.70±0.03
Heart (%of body mass) 0.29±0.01 0.32±0.02 0.31±0.02 0.30±0.02
Spleen (% of body mass) 0.19±0.02 0.16±0.02 0.17±0.02 0.17±0.02
Pancreas(% of body mass) 0.34±0.04 0.32±0.01 0.30±0.03 0.31±0.02
Gonads (% of body mass) 0.94±0.14 1.00±0.12 1.04±0.11 1.06±0.14
Table 4 Biochemical parameters in rats
Parameter Group
C FD FD + ARG FD + ARG + VITC
Glucose (mmol/l) 5.10±0.66 5.22±0.76 4.82±0.60 4.91±0.56
T-CHOL (mmol/l) 2.00±0.09 2.06±0.15 1.90±0.19 1.78±0.13
TG (mmol/l) 0.38±0.09 0.39±0.10 0.40±0.08 0.35±0.08
Insulin (pmol/l) 54.10±10.40a 113.43±12.22c 85.51±5.21b 62.35±10.47a,b
TNF alpha (ng/ml) 5.27±1.23a 8.13±2.18b 7.33±1.75a,b 6.18±1.93a,b
TAS (mmol/l) 1.28±0.12b 0.97±0.21a 1.16±0.10a,b 1.30±0.08b
C control group, FD high-fat diet group, FD + ARG high-fat diet with L-arginine group, FD + ARG + VITC high-fat diet with L-arginine and vitamin C
group, T-ChOL total cholesterol, TG triglycerides, TAS total antioxidant status, TNF alpha tumor necrosis factor alpha; means in the same line with
different superscripts are significantly different (P <0.05)
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of antioxidative–enzyme induction in the body of rats on a
high-fat diet. It is also known that L-arginine may reduce
superoxide anion release from endothelial cells, and thus
affect the lowering of oxidative stress [19, 20]. L-arginine
may lower the amount of free oxygen radicals, and can thus
inhibit tissue damage and decrease inflammation status in rats,
which can promote negative metabolic changes. Increasing
amounts of evidence confirm the anti-inflammatory and anti-
oxidant properties of L-arginine [21–23].
In this study, it was also found that vitamin C did not
significantly impact the effect of L-arginine on insulin, TAS,
TNF alpha, or minerals in rats fed with the high-fat diet. The
combination showed only slightly better effects on insulin,
TNF alpha, and TAS. The results we obtained were not
expected, especially as other studies have shown a beneficial
synergistic effect of the administration of antioxidants with L-
arginine [12, 22, 24, 25]. However, the conditions in these
other studies differed from those obtained in our research. It is
possible that a longer experimental period would reveal sig-
nificant differences between the use of L-arginine alone and of
L-arginine combined with vitamin C. Another explanation is
possibly the lack of synergistic effect of vitamin C and
Table 5 Mineral concentrations
in tissues (μg/g wet wt.)
C control group, FD high-fat diet
group, FD + ARG high-fat diet
with L-arginine group, FD +
ARG + VITC high-fat diet with L-
arginine and vitamin C group;
means in the same line with dif-
ferent superscripts are signifi-
cantly different (P<0.05)
Parameter Group
C FD FD + ARG FD + ARG + VITC
Liver
Ca 24.85±2.60 24.27±4.63 24.53±3.23 32.40±8.82
Mg 262.61±14.93 270.73±10.65 274.21±7.33 246.95±16.28
Fe 63.84±15.05a 116.21±18.51b 99.81±20.62a,b 98.47±20.69a,b
Zn 29.59±1.50 30.70±1.04 30.89±1.20 30.39±2.01
Cu 4.68±0.32 4.93±0.36 4.67±0.27 4.58±0.08
Spleen
Ca 39.50±4.59 34.02±4.63 39.03±4.83 38.45±8.31
Mg 258.51±18.58 258.19±19.53 240.93±6.12 245.54±24.74
Fe 382.47±65.09b 226.14±38.66a 332.02±41.75a,b 328.52±46.25a,b
Zn 19.09±1.68 19.84±1.25 19.73±0.63 19.77±1.63
Cu 0.86±0.07 0.81±0.08 0.69±0.08 0.76±0.10
Heart
Ca 27.55±2.05 28.15±3.85 27.63±1.06 27.43±2.92
Mg 237.32±25.88 242.46±25.05 242.99±14.63 242.22±14.11
Fe 78.15±6.63 67.01±1.38 71.74±0.77 73.34±4.15
Zn 14.76±0.58 15.37±0.37 15.34±0.54 15.34±0.66
Cu 5.00±0.28a 8.37±0.56b 5.15±0.25a 4.91±0.16a
Kidney
Ca 31.48±2.46 30.87±2.62 32.26±1.20 32.17±1.46
Mg 224.89±11.11 223.98±8.74 225.77±13.22 233.74±11.91
Fe 39.53±4.04 49.70±7.96 42.12±6.81 32.61±2.18
Zn 20.96±1.21 21.55±0.65 20.56±0.96 20.91±1.23
Cu 6.76±0.70 6.81±1.17 6.09±1.03 5.84±0.40
Pancreas
Ca 53.24±5.09 68.74±5.40 67.11±2.61 65.80±4.80
Mg 274.42±17.17 272.80±26.91 298.73±14.53 278.74±10.99
Fe 19.64±0.87 18.29±1.09 18.82±2.39 20.30±3.31
Zn 22.27±2.48 20.53±0.58 20.47±1.36 20.40±1.48
Cu 1.03±0.13 0.91±0.08 0.81±0.11 0.78±0.12
Gonads
Ca 16.84±3.22 15.58±5.95 16.55±2.83 16.77±1.30
Mg 151.84±20.82 154.62±13.32 155.43±31.28 151.71±23.62
Fe 24.61±3.48 24.14±3.83 22.32±2.23 22.01±1.63
Zn 38.66±4.79 34.77±3.85 33.22±1.64 31.04±3.47
Cu 2.28±0.43 1.82±0.34 2.03±0.60 1.68±0.20
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arginine. Fan X. et al. [26, 27] have obtained strong evidence
for that hypothesis that the accumulation of ascorbic acid
oxidation products that show high reactivity with proteins is
responsible for the formation of crystalline adducts and
crosslinks in vivo. On one hand, various studies clearly sug-
gest that vitamin C is beneficial for decreasing the risk of
cataractogenesis, in particular under conditions that favor
oxidant stress [28]. The proposed mechanisms include the
scavenging of free radicals by the vitamin itself or in conjunc-
tion with glutathione. On the other hand, it has been observed
that, under some clinical conditions, when the cell’s defenses
are weakened by diabetes, end-stage renal disease, or poor
nutrition, vitamin C can inflict damage [26]. It seems probable
that the high-fat diet used in our experiment could predispose
to carbonyl and oxidant stress, and is also associated with
ascorbic acid oxidation products.
The results of this study show that the influence of L-
arginine in rats, whether alone or with vitamin C, on TAS
and TNF alpha is strongly associated with changes in iron and
copper status. It was observed that the modified diet high in fat
and sodium, which promoted negative metabolic changes,
induced the displacement of iron ions from the spleen to the
liver and the accumulation of copper ions in the heart. These
changes in iron and copper levels in the liver and heart may
negatively influence oxidative stress and inflammation in
these tissues. Iron ions participate in the generation of free
radicals, which may damage hepatic cells and decrease anti-
oxidant status, while increasing inflammation in the body
[29–31]. Similarly, the increase in copper concentration in
the heart of the rats fed with the high-fat diet might induce
oxidative stress in this tissue, and thus determine an inflam-
matory response [32].
In this study, it was found that L-arginine decreased the
displacement of iron ions between the spleen and the liver and
inhibited the accumulation of copper in the heart, in rats fed
with the modified diet. The mechanism of the influence of L-
arginine on iron and copper ions is so far unknown to us,
though it may be connected with the antioxidative and anti-
inflammatory properties of L-arginine [12]. It could also be
linked to the fact that arginine is a substrate in the synthesis of
nitric oxide. Other authors have suggested that NO may play
an important role in iron metabolism [33]. Xiao et al. [33]
found a negative correlation between plasma NO and iron
concentration under conditions of L-arginine supplementation
in exercised rats, such that increases in NO levels during
exercise during L-arginine supplementation were found to
lead to decreased catalytic iron concentration in the liver and
increases in catalytic iron concentration in the spleen. Xiao
et al. [33] also observed changes in nonheme iron and storage
iron in the tissues of rats.
In our previous clinical study, we suggested that changes in
the concentration of minerals under the influence of L-argi-
nine may be linked to the impact of arginine in improving
insulin secretion [6]. In that study, we observed decreases in
copper serum concentration following L-arginine supplemen-
tation. The results of the present study show that the relation
between copper and insulin following L-arginine treatment is
rather indirect. However, the change in copper status is direct-
ly connected with the change in TAS and TNF alpha level.
Other studies support the hypothesis of elevated iron stores, as
well as inflammation and oxidative stress, in the development
of insulin status disorders [6, 34, 35]. The changes in both iron
and copper following the L-arginine supplementation ob-
served in this study may be associated with metabolic rela-
tionships between these elements [36, 37]. Moreover, the
concentration of iron and copper in serum and the tissues is
associated with inflammatory and oxidative stress and with
changes in the levels of these minerals involving amendments
in the parameters of inflammation and antioxidant status
[31, 38].
Our results here show the influence of L -arginine on
insulin status and its effect on TAS and inflammation,
which is strongly connected with the changes in the
iron and copper status of rats fed with the high-fat diet.
The direct mechanism responsible for the change in
minerals following L -arginine supplementation needs
further investigation.
The data obtained in this study is a new finding regarding
the influence of L-arginine, with and without another antiox-
idant, on mineral metabolism in rats with a diet that promotes
metabolic disorders.
This study has its limitations. We did not evaluate mineral
levels in the serum of rats. Ferritin, ceruloplasmin, and
mineral-dependent enzymes (e.g., superoxide dismutase and
catalase), alongside other mineral metabolism parameters and
inflammation and antioxidant markers, were not assessed. The
determination of these parameters would allow a broader
discussion on the impact of L-arginine on mineral status in
rats fed with a high-fat diet. Moreover, in this experiment, the
effect of combining L-arginine and vitamin C was studied on
only one selected level. In further studies, it would be useful to
use different doses of L-arginine in combination with other
antioxidants.
Table 6 Significant correlation indexes between minerals and biochem-
ical parameters (P<0.05)
Parameters r
Fe in liver—serum insulin 0.83
Cu in heart—TAS −0.76
Fe in liver—TAS −0.63
Fe in liver—TNF alpha 0.76
Cu in heart—TNF alpha 0.71
r Pearson correlation coefficient, TAS total antioxidant status, TNF alpha
tumor necrosis factor alpha
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In conclusion, the beneficial influence of L-arginine on
insulin, TAS, and TNF alpha serum level is associated with
changes in iron and copper status in rats fed a high-fat diet.
The effect onmineral status and biochemical parameters of the
administration of L-arginine with vitamin C is similar to that
of supplementation with L-arginine alone in rats fed with the
modified diet promoting negative metabolic changes.
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